MYXOID/ROUND CELL LIPOSARCOMA
Clinical trials for MYXOID/ROUND CELL LIPOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new MYXOID/ROUND CELL LIPOSARCOMA trials appear
Sign up with your email to follow new studies for MYXOID/ROUND CELL LIPOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on rare sarcomas in new trial
Disease control CompletedThis phase 2 trial tests a treatment called Lete-Cel, which uses a patient's own immune cells that have been specially trained to attack cancer cells. It is for people with advanced synovial sarcoma or myxoid/round cell liposarcoma whose tumors have a specific marker (NY-ESO-1) a…
Matched conditions: MYXOID/ROUND CELL LIPOSARCOMA
Phase: PHASE2 • Sponsor: USWM CT, LLC • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New combo therapy shows promise for rare liposarcoma
Disease control CompletedThis phase 2 study tested whether adding pioglitazone (a diabetes drug) to trabectedin (a chemotherapy) could help shrink or control liposarcoma, a rare cancer of fat tissue. The study included 10 patients whose tumors had stopped growing but not shrunk with trabectedin alone. Re…
Matched conditions: MYXOID/ROUND CELL LIPOSARCOMA
Phase: PHASE2 • Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Personalized chemo shows promise against rare sarcomas
Disease control CompletedThis Phase 3 trial tested whether giving chemotherapy based on the specific type of soft tissue sarcoma works better than a one-size-fits-all approach. 550 adults with high-risk sarcomas in the arms or trunk were randomly assigned to standard chemo or a chemo regimen matched to t…
Matched conditions: MYXOID/ROUND CELL LIPOSARCOMA
Phase: PHASE3 • Sponsor: Italian Sarcoma Group • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC